Atorvastatin Tablets Analyzed with HPLC - AppNote
February 18, 2022
/
/
/
Date: 18-FEBRUARY-2022 Last Updated: 16-SEPTEMBER-2026
A Robust Method for Analysis of a Hypercholesterolemia Medication
A robust and reproducible Method has been developed for this Cholesterol medication . A commercially available Drug Product was used as well as a reference Standard. The data below illustrates how the Standards and Drug Product share excellent peak shape using this easy Method.
Peak
1. Top Chromatogram – Atorvastatin Calcium Standard
2. Bottom Chromatogram – Atorvastatin API from Tablets - Generic
Column: Cogent Phenyl Hydride™, 4 μm, 100 Å
Catalog No.: 69020-10P
Dimensions: 4.6 mm x 100 mm
Mobile Phase:
-- A: DI Water with 0.1% Formic Acid
-- B: Acetonitrile with 0.1% Formic Acid
| Time (minutes) | %B |
|---|---|
| 0 | 50 |
| 1 | 50 |
| 5 | 85 |
| 6 | 85 |
| 7 | 50 |
| 8 | 50 |
Flow rate: 1.0 mL/minute
Detection: UV @ 254 nm
Diluent: 50:50 DI Water / Acetonitrile with 0.1% Formic Acid
Standard Preparation: Atorvastatin Calcium standard prepared as 0.1 mg/mL standard solution in diluent.
Sample Preparation: 20 mg strength tablet (Atorvastatin Calcium) was added to a 10 mL volumetric flask with a portion of Diluent. The solution was sonicated 10 minutes and diluted to mark with Diluent. It was then filtered through a 0.45 μm Nylon Syringe Filter. The filtrate was diluted to final concentration of 0.1 mg/mL.
t 0 : 1.2 Minutes
K: 2.15
%RSD of 5 injections: ‹0.1%
Notes : Atorvastatin can treat high cholesterol and triglyceride levels. This may reduce the risk of angina, stroke, heart attack, and heart and blood vessel problems. Atorvastatin is a specific inhibitor of HMGCR (HMG-CoA reductase). HMGCR is the enzyme that catalyzes the conversion of HMG-CoA to Mevalonate, an early step in Cholesterol Biosynthesis. Atorvastatin is used in the treatment of Hypercholesterolemia. Marketed by Pfizer as Lipitor® this AppNote used a generic version.
Notes : Calculation for Capacity Factor - Relative Retention k = (tR-t0)/t0
